Glucosio E Sodio Cloruro Ii Galenica Senese (Sodium Chloride, Glucose Monohydrate)

Glucosio E Sodio Cloruro Ii Galenica Senese is used in clinical settings to manage fluid and electrolyte balance and to provide an energy source.

• Replacement of extracellular fluid losses due to dehydration, surgery, or trauma.
• Correction of hyponatremia or other electrolyte disturbances.
• Treatment of hypoglycemia when rapid glucose delivery is required.
• Support of parenteral nutrition regimens as a source of glucose and sodium chloride.
• Adjunctive therapy during blood transfusion to maintain circulatory volume.

The safety profile of the sodium chloride and glucose injection reflects the expected reactions to intravenous electrolyte solutions.

Common

• Mild pain or irritation at the injection site.
• Transient increase in blood sodium levels.
• Temporary rise in blood glucose concentration.
• Mild nausea or vomiting.

Serious

• Hypernatremia leading to neurological symptoms.
• Severe hyperglycemia or diabetic ketoacidosis in susceptible patients.
• Fluid overload causing pulmonary edema.
• Allergic or anaphylactic reaction to the solution components.

Clinicians should evaluate patient-specific factors before administering Glucosio E Sodio Cloruro Ii Galenica Senese.

• Assess baseline electrolyte and glucose levels to avoid overcorrection.
• Use caution in patients with heart failure, renal impairment, or pulmonary disease due to risk of fluid overload.
• Monitor for signs of hypernatremia or hyperglycemia during and after infusion.
• Adjust infusion rate in neonates, infants, and the elderly.
• Avoid rapid administration in patients with compromised vascular integrity.
• Discontinue if an allergic reaction is suspected.

The intravenous solution may interact with other medications or clinical conditions.

Avoid

• Concomitant administration of hypertonic saline or high‑dose glucose solutions, which can exacerbate electrolyte imbalance.
• Use with drugs that may cause fluid retention, such as corticosteroids, without careful monitoring.

Use with caution

• Diuretics, which can alter sodium balance and require electrolyte monitoring.
• Insulin therapy, because rapid glucose infusion may affect glycemic control.
• Cardiac glycosides, where changes in serum electrolytes can influence drug toxicity.
• Anticoagulants, as large-volume infusions may affect coagulation parameters.